Wills, S. (2018). HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis [Vaccines and Antiviral Agents]. The American Society for Microbiology (ASM).
Chicago Style (17th ed.) CitationWills, S. HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis [Vaccines and Antiviral Agents]. The American Society for Microbiology (ASM), 2018.
MLA (9th ed.) CitationWills, S. HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis [Vaccines and Antiviral Agents]. The American Society for Microbiology (ASM), 2018.
Warning: These citations may not always be 100% accurate.